These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 30281905)

  • 1. Development of novel PLGA nanoparticles with co-encapsulation of docetaxel and abiraterone acetate for a highly efficient delivery into tumor cells.
    Sokol MB; Nikolskaya ED; Yabbarov NG; Zenin VA; Faustova MR; Belov AV; Zhunina OA; Mollaev MD; Zabolotsky AI; Tereshchenko OG; Severin ES
    J Biomed Mater Res B Appl Biomater; 2019 May; 107(4):1150-1158. PubMed ID: 30281905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.
    Ahmad N; Alam MA; Ahmad R; Naqvi AA; Ahmad FJ
    Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):432-446. PubMed ID: 28503995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells.
    Abou-El-Naga AM; Mutawa G; El-Sherbiny IM; Mousa SA
    Int J Nanomedicine; 2018; 13():8153-8164. PubMed ID: 30555232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy.
    Emami F; Duwa R; Banstola A; Woo SM; Kwon TK; Yook S
    Biomed Pharmacother; 2023 Sep; 165():115023. PubMed ID: 37329708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies.
    Sanna V; Roggio AM; Posadino AM; Cossu A; Marceddu S; Mariani A; Alzari V; Uzzau S; Pintus G; Sechi M
    Nanoscale Res Lett; 2011 Mar; 6(1):260. PubMed ID: 21711774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Docetaxel-loaded human serum albumin (HSA) nanoparticles: synthesis, characterization, and evaluation.
    Qu N; Sun Y; Li Y; Hao F; Qiu P; Teng L; Xie J; Gao Y
    Biomed Eng Online; 2019 Jan; 18(1):11. PubMed ID: 30704488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.
    Badran MM; Alomrani AH; Harisa GI; Ashour AE; Kumar A; Yassin AE
    Biomed Pharmacother; 2018 Oct; 106():1461-1468. PubMed ID: 30119220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel-loaded polylactic acid-co-glycolic acid nanoparticles: formulation, physicochemical characterization and cytotoxicity studies.
    Pradhan R; Poudel BK; Ramasamy T; Choi HG; Yong CS; Kim JO
    J Nanosci Nanotechnol; 2013 Aug; 13(8):5948-56. PubMed ID: 23882865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinspired nanocarriers for an effective chemotherapy of hepatocellular carcinoma.
    Xu L; Wu S; Zhou X
    J Biomater Appl; 2018 Jul; 33(1):72-81. PubMed ID: 29699442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-delivery of Docetaxel and Disulfonate Tetraphenyl Chlorin in One Nanoparticle Produces Strong Synergism between Chemo- and Photodynamic Therapy in Drug-Sensitive and -Resistant Cancer Cells.
    Gaio E; Conte C; Esposito D; Miotto G; Quaglia F; Moret F; Reddi E
    Mol Pharm; 2018 Oct; 15(10):4599-4611. PubMed ID: 30148955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
    Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Characterization of a Fucoidan-Based Drug Delivery System by Using Hydrophilic Anticancer Polysaccharides to Simultaneously Deliver Hydrophobic Anticancer Drugs.
    Lai YH; Chiang CS; Hsu CH; Cheng HW; Chen SY
    Biomolecules; 2020 Jun; 10(7):. PubMed ID: 32605162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.
    Zhu H; Chen H; Zeng X; Wang Z; Zhang X; Wu Y; Gao Y; Zhang J; Liu K; Liu R; Cai L; Mei L; Feng SS
    Biomaterials; 2014 Feb; 35(7):2391-400. PubMed ID: 24360574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
    Wang X; Cheng R; Zhong Z
    Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management.
    Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S
    Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long circulating PEGylated poly(D,L-lactide-co-glycolide) nanoparticulate delivery of Docetaxel to solid tumors.
    Senthilkumar M; Mishra P; Jain NK
    J Drug Target; 2008 Jun; 16(5):424-35. PubMed ID: 18569287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved mucoadhesion and cell uptake of chitosan and chitosan oligosaccharide surface-modified polymer nanoparticles for mucosal delivery of proteins.
    Dyawanapelly S; Koli U; Dharamdasani V; Jain R; Dandekar P
    Drug Deliv Transl Res; 2016 Aug; 6(4):365-79. PubMed ID: 27106502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-Delivery of Docetaxel and Salinomycin to Target Both Breast Cancer Cells and Stem Cells by PLGA/TPGS Nanoparticles.
    Gao J; Liu J; Xie F; Lu Y; Yin C; Shen X
    Int J Nanomedicine; 2019; 14():9199-9216. PubMed ID: 32063706
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design of PLGA nanoparticles for sustained release of hydroxyl-FK866 by microfluidics.
    Bai X; Tang S; Butterworth S; Tirella A
    Biomater Adv; 2023 Nov; 154():213649. PubMed ID: 37820459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tumor efficacy of folate modified PLGA-based nanoparticles for the co-delivery of drugs in ovarian cancer.
    Li S; Li X; Ding J; Han L; Guo X
    Drug Des Devel Ther; 2019; 13():1271-1280. PubMed ID: 31114163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.